False Claims Act Update & Alert
	Taxpayers Against Fraud Education Fund | Washington, D.C. | WWW.TAF.ORG           March 10, 2009
	.
		Subscribe to this FREE Newsletter Enter your Email Powered by FeedBlitz n TAF Home Page n Previous Newsletters n Email editor   Please take a moment to forward this FREE electronic newsletter to others that might be interested!	US Joins Against NM Hospitals DoJ has joined a False Claims Act case against Community Health Systems Inc., and three of its hospitals in New Mexico. CHS is charged with violating the FCA by knowingly causing to be presented false claims for federal matching Medicaid funds.  CHS paid New Mexico counties knowing that the money would then be used to illegally obtain triple that amount in federal funding, which would then be paid back to CHS under New Mexico's Medicaid program.  >> To read more
			Massive Amgen Fraud Case An unidentified whistleblower has filed a False Claims Act case against Amgen, the biotechnology company which makes arthritis and psoriasis drug Enbrel, and anti-anemia drug Aranesp. Amerisource-Bergen and online health-information provider WebMD Health Corp are also named.  The case came out from under seal at a judge's directive, and DoJ is still deciding if it will join. The case involves off-label marketing, kickbacks and Medicaid best price violations.  >> To read more
			DoJ Joins Against Forest DoJ has charged Forest Laboratories with defrauding the government by illegally marketing the antidepressants Celexa and Lexapro for unapproved use in children and teenagers. Prosecutors charge former top executives at Forest with concealing a clinical study that showed that Celexa and Lexapro were not effective in children and might even pose risks, including causing some to become suicidal.  >> To read more
			FDA Says Ranbaxy Faked Data The Food and Drug Administration has accused Ranbaxy, an Indian generic drug maker, of falsifying data and test results in order to get drug approvals. The faked data supported application for medications that had already been approved and for pending applications for new drugs permits.  The FDA has previously stopped all new shipments of Ranbaxy drugs into the U.S.  >> To read more
			NY Medicaid Fraud Recoveries Exceeding Expectations In 2008, New York recovered over $550 million in “improperly paid” Medicaid payments, more than twice the $215 million target the federal government set for the state. >> To read more
			.
			..